| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $35.0M | +29.7% |
| Cost of Revenue | $15.8M | +6.1% |
| Gross Profit | $19.1M | +59.0% |
| R&D Expense | $0 | — |
| SG&A Expense | $11.6M | +3.3% |
| Operating Income | $6.1M | +855.7% |
| Pre-tax Income | $5.8M | +8339.4% |
| Net Income | $5.8M | +7144.5% |
| EPS (Basic) | $0.01 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.7M | -28.7% |
| Accounts Receivable | $188K | +653.7% |
| Current Assets | $58.3M | +63.9% |
| Total Assets | $64.1M | +53.1% |
| Current Liabilities | $40.5M | +52.8% |
| Total Liabilities | $41.4M | +51.0% |
| Stockholders' Equity | $22.7M | +57.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$40.9M | -465.5% |
| Investing Cash Flow | $11.7M | +2524.2% |
| Financing Cash Flow | $21.2M | +8178.9% |
| — |
| EPS (Diluted) | $0.01 | — |